Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May;141(5):1080-8.
doi: 10.1017/S0950268812001367. Epub 2012 Jul 17.

Force of infection of dengue serotypes in a population-based study in the northeast of Brazil

Affiliations

Force of infection of dengue serotypes in a population-based study in the northeast of Brazil

P M S Castanha et al. Epidemiol Infect. 2013 May.

Abstract

This study investigated anti-dengue serotype-specific neutralizing antibodies in a random sample of dengue IgG-positive individuals identified in a survey performed in a hyperendemic setting in northeastern Brazil in 2005. Of 323 individuals, 174 (53.8%) had antibodies to dengue virus serotype 1 (DENV-1), 104 (32.2%) to DENV-2 and 301 (93.2%) to DENV-3. Monotypic infections by DENV-3 were the most frequent infection (35.6%). Of 109 individuals aged <15 years, 61.5% presented multitypic infections. The force of infection estimated by a catalytic model was 0.9%, 0.4% and 2.5% person-years for DENV-1, DENV-2 and DENV-3, respectively. By the age of 5 years, about 70%, 30% and 40% of participants were immune to DENV-3, DENV-2 and DENV-1, respectively. The data suggest that infection with DENV-1, -2 and -3 is intense at early ages, demonstrating the need for research efforts to investigate dengue infection in representative population samples of Brazilian children during early infancy.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Estimated susceptible population for DENV-1, -2 and -3 according to age by a catalytic model. Recife, Brazil, 2005–2006.
Fig. 2.
Fig. 2.
Antibodies titres (log10) according to dengue serotypes between individuals aged <15 years who had serological markers to three dengue serotypes (P<0·001).

Similar articles

Cited by

References

    1. Guzman MG, et al. Dengue: a continuing global threat. Nature Reviews Microbiology 2010; 8: S7–16. - PMC - PubMed
    1. San Martin JL, et al. The epidemiology of dengue in the americas over the last three decades: a worrisome reality. American Journal of Tropical Medicine and Hygiene 2010; 82: 128–135. - PMC - PubMed
    1. Teixeira MG, et al. Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica 2009; 25: S7–18. - PubMed
    1. Swaminathan S, Batra G, Khanna N. Dengue vaccines: state of the art. Expert Opinion on Therapeutic Patents 2010; 20: 819–835. - PubMed
    1. Kyle JL, Harris E. Global spread and persistence of dengue. Annual Review of Microbiology 2008; 62: 71–92. - PubMed

Publication types